Research in Motion ( RIMM) estimates cut at JP Morgan through 2014, JP Morgan said. Weaker outlook for Blackberry 7 sales.

Sarepta ( SRPT) estimates, target boosted at JMP. Shares of SRPT now seen reaching $50, according to JMP Securities. Estimates also upped, given the clinical efficacy of its muscular dystrophy drug. Outperform rating.

>To submit a news tip, email: tips@thestreet.com.

READERS ALSO LIKE:


Follow TheStreet on Twitter and become a fan on Facebook.
This article was written by a staff member of TheStreet.

If you liked this article you might like

The #DigitalSkeptic Guide To Mobile Gadgets that Won't Break on You

5 Telecommunications Stocks Nudging The Industry Higher

Research In Motion Ltd (RIMM): Today's Featured Telecommunications Laggard

5 Stocks Pulling The Telecommunications Industry Downward

Research In Motion Ltd (RIMM): Today's Featured Telecommunications Laggard